levodopa has been researched along with Atrophy in 61 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (24.59) | 18.7374 |
1990's | 21 (34.43) | 18.2507 |
2000's | 10 (16.39) | 29.6817 |
2010's | 10 (16.39) | 24.3611 |
2020's | 5 (8.20) | 2.80 |
Authors | Studies |
---|---|
Adachi, T; Hanajima, R; Hasegawa, M; Sakata, R; Sakuwa, M; Suzuki, Y; Takigawa, H | 1 |
Fasano, A; Gorodetsky, C; Lang, AE; Lozano, AM; Youn, J | 1 |
Chelban, V; Cortese, A; Houlden, H; O'Connor, E; Rossi, S; Sullivan, R; Wood, NW; Yau, WY | 1 |
Chung, SJ | 1 |
Bocci, T; Bongioanni, P; Orlandi, G; Santin, M; Sartucci, F | 1 |
Giladi, N; Hausdorff, JM; Hendler, T; Herman, T; Jacob, Y; Rosenberg-Katz, K | 1 |
Barone, P; Bovi, T; Censi, D; Fasano, A; Juergenson, I; Montemezzi, S; Squintani, G; Tinazzi, M; Vattemi, G | 1 |
Miletić, V; Ozretić, D; Relja, M | 1 |
Camicioli, R; Emery, D; Gee, M; Sabino, J; Sapkota, S | 1 |
Costello, D; Lynch, T; McCarthy, A; Mulroy, E; Ross, OA | 1 |
D'Abreu, A; França, MC; Friedman, JH; Lopes-Cendes, I; Martinez, AR; Nunes, MB; Rezende, TJ | 1 |
Goto, Y; Isozaki, E; Sunami, Y; Warabi, Y | 1 |
Adam, OR; Ferrara, JM; Ondo, WG | 1 |
Damon-Perrière, N; Meissner, WG; Tison, F | 1 |
Arami, MA; Ayromlou, H; Najmi, S | 1 |
Chang, HC; Chen, RS; Lu, CS; Tsai, CH; Wu Chou, YH; Yen, TC | 1 |
Bakay, RA; Barnhart, H; Chockkan, V; DeLong, MR; Evatt, M; Freeman, A; Green, J; Haber, M; McDonald, W; Mewes, K; Triche, S; Vitek, JL; Wahlay, N; Zhang, JY | 1 |
Apetauerova, D; Norregaard, T; Ryan, P; Tarsy, D | 1 |
Berciano, J; Combarros, O; Corral, J; Infante, J; Pascual, J; Polo, JM; Volpini, V | 1 |
Funakawa, I; Katayama, S; Konishi, Y; Shirabe, T; Terao, A | 1 |
Balci, K; Celik, Y; Kabayel, L; Turgut, N | 1 |
Haginoya, K; Higano, S; Iinuma, K; Ishitobi, M; Kitamura, T; Nara, T; Onuma, A; Togashi, N; Wakusawa, K; Yokoyama, H | 1 |
Mercimek-Mahmutoglu, S; Stockler-Ipsiroglu, S | 1 |
Bargalló, N; Giménez, M; Junqué, C; Martí, MJ; Ramírez-Ruiz, B; Tolosa, E; Valldeoriola, F | 1 |
He, QJ; Xu, SQ | 1 |
Mayeux, R; Stern, Y | 1 |
Goetz, CG; Klawans, HL; Tanner, CM | 1 |
Goldman, JW; Haldeman, S; Hyde, J; Pribram, HF | 1 |
Ciannella, L; Dell'Aria, V; Melone, MA | 2 |
Angelini, L; Broggi, G; Mainini, P; Moretti, G; Nardocci, N | 1 |
Duvoisin, RC; Mark, MH; Miller, DC; Sage, JI; Walters, AS | 1 |
Bressi, S; Caraceni, T; Cortelli, P; Fazio, F; Gentrini, S; Grassi, F; Perani, D; Savoiardo, M; Testa, D | 1 |
Golbe, LI; Goodman, JC; Jankovic, J; Rajput, AH | 1 |
Fénelon, G; Feve, A; Guillard, A; Mahieux, F; Romatet, S | 1 |
Churchyard, A; Donnan, GA; Howells, DW; Hughes, A; Kalnins, RM; Mendelsohn, FA; Paxinos, G; Wong, JY; Woodhouse, D | 1 |
Bergmans, PL; Konings, CH; Kuiper, MA; Wolters, EC | 1 |
Benhadjali, J; Bughin, M; Delalande, I; Destée, A; Forzy, G; Hache, JC | 1 |
Albanese, A; Colosimo, C; Lees, AJ; Tonali, P | 1 |
Cooper, JM; Daniel, SE; Gash, MT; Gu, M; Marsden, CD; Quinn, NP; Schapira, AH; Wenning, GK | 1 |
Caraceni, T; Fetoni, V; Genitrini, S; Girotti, F; Monza, D; Soliveri, P; Testa, D | 1 |
Kimber, JR; Mathias, CJ; Watson, L | 1 |
Arnold, G; Gasser, T; Oertel, WH; Schwarz, J; Tatsch, K | 1 |
De Mari, M; Federico, F; Giannini, P; Iliceto, G; Lamberti, P; Lucivero, V; Mezzapesa, DM; Simone, IL; Tarantino, A | 1 |
Pearce, JM | 1 |
Becker, H; Beyer, M; Fischer, PA; Jacobi, P; Schneider, E | 1 |
Becker, H; Fischer, PA; Hacker, H; Jacobi, P; Schneider, E | 1 |
Hoehn, MM; Kelts, KA | 1 |
Burguera, JA; Carrera, N; Delgado, G; Marti Massó, JF; Martínez Lage, JM | 1 |
Coper, H; Hausmanowa-Petrusewicz, I; Kaminska, A; Ossowska, K; Schulze, G; Wolfarth, S | 1 |
Colosimo, C; Daniel, SE; Hughes, AJ; Kleedorfer, B; Lees, AJ | 1 |
Dubas, F; Henin, D; Vidailhet, M | 1 |
Marsden, CD; Pires, M; Quinn, NP; Scaravilli, F; Steiger, MJ | 1 |
Ardouin, C; Crouzet, G; Durif, F; Hommel, M; Le Bas, JF; Perret, J; Pollak, P | 1 |
Court, J; Godoy, J; Valenzuela, R | 1 |
Caraceni, T | 1 |
Burke, RE; Fahn, S; Giladi, N; Gordon, M; Hunt, A; Kostic, V; Przedborski, S | 1 |
Harvey, NS | 1 |
Adam, MJ; Ammann, W; Beattie, BL; Calne, DB; Harrop, R; Kamo, H; Li, DK; McGeer, EG; McGeer, PL; Tuokko, H | 1 |
Artieda, J; Luquin, MR; Martínez Lage, JM; Obeso, JA; Tuñón, T | 1 |
5 review(s) available for levodopa and Atrophy
Article | Year |
---|---|
[Multiple system atrophy].
Topics: Aged; Antiparkinson Agents; Atrophy; Brain; Combined Modality Therapy; Cross-Sectional Studies; Humans; Levodopa; Magnetic Resonance Imaging; Multiple System Atrophy; Neurologic Examination; Palliative Care; Parkinsonian Disorders; Physical Therapy Modalities; Prognosis; Survival Rate | 2010 |
Intellectual dysfunction and dementia in Parkinson disease.
Topics: Aged; Atrophy; Basal Ganglia; Cerebral Cortex; Dementia; Humans; Intelligence; Levodopa; Middle Aged; Parkinson Disease; Psychological Tests | 1983 |
Aetiology and natural history of Parkinson's disease.
Topics: Aged; Atrophy; Brain; Dopamine; Female; Humans; Levodopa; Male; Middle Aged; Neurotransmitter Agents; Parkinson Disease; Prognosis; Substantia Nigra | 1978 |
Psychiatric disorders in parkinsonism: 2. Organic cerebral states and drug reactions.
Topics: Amantadine; Antiparkinson Agents; Atrophy; Brain; Bromocriptine; Cognition; Dementia; Dreams; Drug Interactions; Ergolines; Humans; Levodopa; Libido; Memory; Parasympatholytics; Parkinson Disease; Receptors, Dopamine; Sexual Behavior; Substance-Related Disorders; Visual Perception | 1986 |
Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Atrophy; Cerebellar Cortex; Cerebral Cortex; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Magnetic Resonance Spectroscopy; Male; Middle Aged; Oxygen; Psychological Tests; Radioisotopes; Tomography, Emission-Computed; Tomography, X-Ray Computed; Water | 1986 |
5 trial(s) available for levodopa and Atrophy
Article | Year |
---|---|
Dystonia in Machado-Joseph disease: Clinical profile, therapy and anatomical basis.
Topics: Adult; Ataxin-3; Atrophy; Botulinum Toxins, Type A; Brain; Diffusion Tensor Imaging; Dystonic Disorders; Female; Gray Matter; Humans; Levodopa; Machado-Joseph Disease; Magnetic Resonance Imaging; Male; Middle Aged; Motor Cortex; Repressor Proteins; Severity of Illness Index; Single-Blind Method; Thalamus; Trinucleotide Repeats; Videotape Recording; White Matter | 2015 |
Randomized trial of pallidotomy versus medical therapy for Parkinson's disease.
Topics: Antiparkinson Agents; Atrophy; Brain; Carbidopa; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Combinations; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Globus Pallidus; Humans; Hypokinesia; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Rigidity; Neurosurgical Procedures; Parkinson Disease; Severity of Illness Index; Treatment Outcome; Tremor | 2003 |
Visual evoked potentials and spatiotemporal contrast sensitivity changes in idiopathic Parkinson's disease and multiple system atrophy.
Topics: Aged; Antiparkinson Agents; Atrophy; Contrast Sensitivity; Evoked Potentials, Visual; Female; Humans; Levodopa; Male; Middle Aged; Motion Perception; Movement; Nervous System Diseases; Parkinson Disease; Space Perception; Time Perception; Vision, Monocular | 1996 |
The clinical diagnosis of multiple system atrophy presenting as pure parkinsonism.
Topics: Aged; Antiparkinson Agents; Atrophy; Autonomic Nervous System; Brain; Dopamine Agents; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Nervous System Diseases; Parkinson Disease; Prospective Studies; Retrospective Studies | 1996 |
[123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapy.
Topics: Adult; Aged; Apomorphine; Atrophy; Benzamides; Binding Sites; Cerebral Cortex; Dopamine; Dopamine Agonists; Dopamine Antagonists; Follow-Up Studies; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Parkinson Disease; Predictive Value of Tests; Putamen; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon | 1997 |
51 other study(ies) available for levodopa and Atrophy
Article | Year |
---|---|
An autopsy case of progressive supranuclear palsy. Pallido-nigro-luysian type with argyrophilic grains clinically presenting with personality and behavioral changes.
Topics: Aged; Aged, 80 and over; Atrophy; Autopsy; Humans; Levodopa; Male; Neurodegenerative Diseases; Personality; Supranuclear Palsy, Progressive; tau Proteins | 2022 |
Hemiatrophy-hemiparkinsonism and Poland syndrome: A causative or coincidental association?
Topics: Atrophy; Humans; Levodopa; Parkinson Disease; Parkinsonian Disorders; Poland Syndrome | 2023 |
Dopa-Responsive Parkinsonism in a Patient With Homozygous RFC1 Expansions.
Topics: Atrophy; Humans; Levodopa; Multiple System Atrophy; Parkinsonian Disorders | 2020 |
Subcortical and brainstem hemiatrophy accompanied by iron deposition in a patient with hemiparkinsonism-hemiatrophy syndrome: a case report.
Topics: Antiparkinson Agents; Atrophy; Brain; Functional Laterality; Humans; Iron; Levodopa; Magnetic Resonance Imaging; Male; Parkinsonian Disorders; Young Adult | 2021 |
High-resolution ultrasound changes of the vagus nerve in idiopathic Parkinson's disease (IPD): a possible additional index of disease.
Topics: Aged; Aged, 80 and over; Atrophy; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Ultrasonography; Vagus Nerve | 2021 |
Gray matter atrophy distinguishes between Parkinson disease motor subtypes.
Topics: Aged; Antiparkinson Agents; Atrophy; Brain; Cognition; Data Interpretation, Statistical; Female; Gait Disorders, Neurologic; Humans; Image Processing, Computer-Assisted; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Movement Disorders; Nerve Net; Neural Pathways; Neuropsychological Tests; Parkinson Disease; Psychomotor Performance; Risk Factors | 2013 |
Pisa syndrome in Parkinson's disease: an electrophysiological and imaging study.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Atrophy; Dystonia; Electromyography; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Paraspinal Muscles; Parkinson Disease; Posture; Radiography; Spine; Thorax | 2013 |
Parkinsonian syndrome and ataxia as a presenting finding of acquired hepatocerebral degeneration.
Topics: Antiparkinson Agents; Ataxia; Atrophy; Brain; Diagnosis, Differential; Female; Hepatic Encephalopathy; Humans; Levodopa; Liver Cirrhosis, Alcoholic; Magnetic Resonance Imaging; Middle Aged; Parkinsonian Disorders; Wine | 2014 |
Association of homocysteine with ventricular dilatation and brain atrophy in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Atrophy; Brain; Dilatation; Female; Homocysteine; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 2014 |
Asymmetrical leg atrophy in levodopa-responsive dystonia due to a novel GTP cyclohydrolase mutation.
Topics: Adult; Atrophy; Dystonia; Genetic Predisposition to Disease; Genetic Testing; GTP Cyclohydrolase; Humans; Leg; Levodopa; Male; Mutation | 2014 |
Dopa-responsive acute disseminated encephalomyelitis with marked atrophy of the striate body.
Topics: Adolescent; Antiparkinson Agents; Atrophy; Corpus Striatum; Encephalomyelitis, Acute Disseminated; Humans; Hypothermia; Levodopa; Magnetic Resonance Imaging; Male; Vomiting | 2016 |
Levodopa-induced dyskinesias in spinocerebellar ataxia type 2.
Topics: Antiparkinson Agents; Atrophy; Depressive Disorder; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Parkinsonian Disorders; Rhombencephalon; Spinocerebellar Ataxias | 2010 |
Hemiparkinsonism-hemiatrophy syndrome.
Topics: Adult; Antiparkinson Agents; Atrophy; Benzothiazoles; Biperiden; Carbidopa; Cerebral Cortex; Cerebral Ventricles; Dopamine Agonists; Drug Combinations; Humans; Indans; Levodopa; Magnetic Resonance Imaging; Male; Monoamine Oxidase Inhibitors; Parkinson Disease, Secondary; Pramipexole; Tomography, X-Ray Computed | 2011 |
Dopa-responsive parkinsonism phenotype of spinocerebellar ataxia type 2.
Topics: Aged; Atrophy; Cerebellum; Corpus Striatum; Dopamine Agonists; Genotype; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Organotechnetium Compounds; Parkinsonian Disorders; Pedigree; Pons; Radiopharmaceuticals; Spinocerebellar Ataxias; Substantia Nigra; Tomography, Emission-Computed, Single-Photon; Tropanes | 2002 |
Adverse effects of subthalamic nucleus DBS in a patient with multiple system atrophy.
Topics: Antiparkinson Agents; Atrophy; Carbidopa; Combined Modality Therapy; Contraindications; Deglutition Disorders; Diagnosis, Differential; Dysarthria; Electric Stimulation Therapy; Electrodes, Implanted; Female; Humans; Levodopa; Magnetic Resonance Imaging; Microelectrodes; Middle Aged; Multiple System Atrophy; Parkinson Disease; Pons; Putamen; Subthalamic Nucleus | 2003 |
Spinocerebellar ataxia type 2 with Levodopa-responsive parkinsonism culminating in motor neuron disease.
Topics: Alleles; Antiparkinson Agents; Atrophy; Brain Stem; Female; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Motor Neuron Disease; Parkinsonian Disorders; Pedigree; Phenotype; Spinocerebellar Ataxias | 2004 |
Autopsy case of pure akinesia showing pallidonigro-luysian atrophy.
Topics: Atrophy; Brain; Dopamine Agonists; Drug Resistance; Gait Apraxia; Humans; Immunohistochemistry; Levodopa; Male; Middle Aged; Neurodegenerative Diseases; Plaque, Amyloid | 2005 |
Proximal myotonic dystrophy associated with parkinsonism.
Topics: Adult; Antiparkinson Agents; Atrophy; Electromyography; Female; Humans; Levodopa; Magnetic Resonance Imaging; Muscle Weakness; Myotonic Disorders; Parkinson Disease; Tomography, X-Ray Computed | 2006 |
Effective treatment with levodopa and carbidopa for hypomyelination with atrophy of the basal ganglia and cerebellum.
Topics: Administration, Oral; Antiparkinson Agents; Atrophy; Basal Ganglia; Carbidopa; Cerebellum; Child, Preschool; Demyelinating Diseases; Diagnosis, Differential; Drug Therapy, Combination; Dystonia; Fluorodeoxyglucose F18; Humans; Levodopa; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Spinocerebellar Degenerations; Treatment Outcome | 2006 |
Cerebral folate deficiency and folinic acid treatment in hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC) syndrome.
Topics: Antiparkinson Agents; Atrophy; Basal Ganglia; Brain Diseases, Metabolic; Carbidopa; Cerebellum; Demyelinating Diseases; Dystonia; Female; Folic Acid Deficiency; Humans; Leucovorin; Levodopa; Male; Syndrome; Tetrahydrofolates; Treatment Outcome; Vitamin B Complex | 2007 |
Cerebral atrophy in Parkinson's disease patients with visual hallucinations.
Topics: Antiparkinson Agents; Antipsychotic Agents; Atrophy; Cerebral Cortex; Female; Hallucinations; Humans; Levodopa; Magnetic Resonance Imaging; Male; Parietal Lobe; Parkinson Disease; Severity of Illness Index; Temporal Lobe; Visual Cortex; Visual Pathways | 2007 |
[Effects of Maidang Rutong granule on l-dopa-induced galactozemia in rats].
Topics: Animals; Animals, Newborn; Atrophy; Body Weight; Drug Combinations; Drugs, Chinese Herbal; Female; Lactation; Lactation Disorders; Levodopa; Male; Mammary Glands, Animal; Prolactin; Random Allocation; Rats; Rats, Sprague-Dawley | 2007 |
The pharmacology of olivopontocerebellar atrophy.
Topics: Adult; Amantadine; Atrophy; Baclofen; Brain Diseases; Carbidopa; Cerebellar Ataxia; Female; Humans; Levodopa; Male; Middle Aged; Olivary Nucleus; Pons; Propranolol; Syndrome | 1984 |
Levodopa: long-term impact on Parkinson's disease.
Topics: Atrophy; Cerebral Cortex; Dementia; Hallucinations; Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced | 1981 |
Progressive supranuclear palsy, computed tomography, and response to antiparkinsonian drugs.
Topics: Aged; Atrophy; Basal Ganglia Diseases; Benztropine; Cerebellum; Eye Movements; Humans; Levodopa; Male; Mesencephalon; Middle Aged; Parkinson Disease; Speech; Tomography, X-Ray Computed; Tropanes | 1981 |
[L-dopa-resistant parkinsonism with cerebral atrophy: striato-nigral degeneration? 2 cases].
Topics: Atrophy; Brain; Corpus Striatum; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Substantia Nigra | 1981 |
[L-dopa-resistant Parkinson's disease with cerebral atrophy: striato-nigral degeneration?].
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Atrophy; Brain Diseases; Corpus Striatum; Female; Humans; Levodopa; Male; Middle Aged; Nerve Degeneration; Parkinson Disease; Substantia Nigra | 1981 |
A perplexing case of juvenile extrapyramidal disease.
Topics: Adolescent; Atrophy; Basal Ganglia Diseases; Bromocriptine; Electroencephalography; Female; Globus Pallidus; Humans; Levodopa; Parkinson Disease, Secondary; Tomography, X-Ray Computed | 1981 |
Binswanger's disease presenting as levodopa-responsive parkinsonism: clinicopathologic study of three cases.
Topics: Aged; Atrophy; Brain; Cerebral Arteries; Dementia, Multi-Infarct; Female; Humans; Intracranial Arteriosclerosis; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Supranuclear Palsy, Progressive | 1995 |
Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study.
Topics: Atrophy; Brain Diseases; Corpus Striatum; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Male; Middle Aged; Olivopontocerebellar Atrophies; Parkinson Disease; Substantia Nigra; Tomography, Emission-Computed | 1995 |
What is it? Case 1, 1993: parkinsonism, dysautonomia, and ophthalmoparesis.
Topics: Atrophy; Autonomic Nervous System Diseases; Brain; Carbon Monoxide Poisoning; Deglutition Disorders; Diagnosis, Differential; Female; Humans; Levodopa; Middle Aged; Neurologic Examination; Ophthalmoplegia; Parkinson Disease | 1993 |
[Parkinsonian features of Steele-Richardson-Olszewski syndrome].
Topics: Aged; Atrophy; Brain Stem; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Supranuclear Palsy, Progressive; Tomography, X-Ray Computed | 1993 |
Dopa resistance in multiple-system atrophy: loss of postsynaptic D2 receptors.
Topics: Aged; Atrophy; Autoradiography; Corpus Striatum; Drug Resistance; Female; Humans; Levodopa; Male; Parkinson Disease; Putamen; Receptors, Dopamine D1; Receptors, Dopamine D2; Synapses | 1993 |
Whole blood monoamine oxidase activity in Parkinson's disease and multiple system atrophy patients.
Topics: Aged; Aged, 80 and over; Atrophy; Basal Ganglia Diseases; Blood Platelets; Brain; Dopamine; Enzyme Induction; Female; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase; Olivopontocerebellar Atrophies; Parkinson Disease; Shy-Drager Syndrome | 1993 |
Mitochondrial respiratory chain function in multiple system atrophy.
Topics: Aged; Antiparkinson Agents; Atrophy; Blood Platelets; Brain; Citrate (si)-Synthase; Culture Techniques; Electron Transport; Humans; Levodopa; Middle Aged; Mitochondria; Nerve Degeneration; Parkinson Disease; Substantia Nigra | 1997 |
Variations in axial, proximal, and distal motor response to L-dopa in multisystem atrophy and Parkinson's disease.
Topics: Aged; Atrophy; Female; Gait; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease | 1997 |
Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine.
Topics: Adrenergic alpha-Agonists; Atrophy; Autonomic Nervous System Diseases; Clonidine; Diagnosis, Differential; Dopamine; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Levodopa; Middle Aged; Norepinephrine; Parkinson Disease | 1997 |
Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders.
Topics: Aged; Antiparkinson Agents; Aspartic Acid; Atrophy; Cerebral Cortex; Choline; Corpus Striatum; Creatinine; Female; Globus Pallidus; Humans; Levodopa; Magnetic Resonance Spectroscopy; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Phosphocreatine; Protons; Putamen; Supranuclear Palsy, Progressive | 1997 |
Cerebral atrophy and long-term response to levodopa in Parkinson's disease.
Topics: Adult; Aged; Atrophy; Brain; Cerebral Cortex; Cerebral Ventricles; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prognosis; Time Factors; Tomography, X-Ray Computed | 1979 |
The significance of cerebral atrophy for the symptomatology of Parkinson's disease.
Topics: Adult; Aged; Atrophy; Brain; Cerebral Cortex; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychological Tests; Tomography, X-Ray Computed | 1979 |
Hypothalamic atrophy.
Topics: Adult; Atrophy; Brain Diseases; Cerebellum; Cerebral Ventricles; Humans; Hypertrophy; Hypothalamus; Levodopa; Male; Middle Aged; Pneumoencephalography; Receptors, Adrenergic; Receptors, Dopamine | 1978 |
[Olivary-ponto-cerebellar atrophy with vegetative disorders treated with levodopa].
Topics: Atrophy; Cerebellar Diseases; Humans; Levodopa; Male; Middle Aged; Olivary Nucleus; Pneumoencephalography; Pons | 1977 |
Muscle stiffness and continuous electromyographic activity in old rats; an animal model for spasticity?
Topics: Aging; Animals; Atrophy; Baclofen; Benserazide; Drug Combinations; Electromyography; Female; Levodopa; Muscle Contraction; Muscle Denervation; Muscle Spasticity; Muscle Tonus; Muscles; Rats; Rats, Wistar | 1992 |
The dopaminergic response in multiple system atrophy.
Topics: Adult; Aged; Apomorphine; Atrophy; Brain Stem; Female; Humans; Injections, Subcutaneous; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease; Terminology as Topic | 1992 |
[A case at Salpêtrière hospital November 1990. Parkinson syndrome with poor response to dopa therapy in a 64 year-old man].
Topics: Atrophy; Corpus Striatum; Diagnosis, Differential; Drug Resistance; Humans; Levodopa; Male; Middle Aged; Olivopontocerebellar Atrophies; Parkinson Disease, Secondary; Substantia Nigra; Supranuclear Palsy, Progressive | 1992 |
Hemiballism and chorea in a patient with parkinsonism due to a multisystem degeneration.
Topics: Aged; Antiparkinson Agents; Atrophy; Brain; Carbidopa; Central Nervous System Diseases; Chorea; Diagnosis, Differential; Drug Combinations; Female; Humans; Levodopa; Movement Disorders; Nerve Degeneration; Parkinson Disease; Spinal Cord | 1992 |
Relationship between levodopa-independent symptoms and central atrophy evaluated by magnetic resonance imaging in Parkinson's disease.
Topics: Aged; Atrophy; Female; Frontal Lobe; Humans; Levodopa; Magnetic Resonance Imaging; Male; Neurologic Examination; Parkinson Disease | 1992 |
Delayed cyanide induced dystonia.
Topics: Adolescent; Adult; Apomorphine; Atrophy; Brain Damage, Chronic; Cerebral Cortex; Dystonia; Electroencephalography; Follow-Up Studies; Humans; Levodopa; Male; Neurologic Examination; Potassium Cyanide; Putamen; Reaction Time | 1992 |
The diagnosis of multiple system atrophy.
Topics: Atrophy; Autonomic Nervous System Diseases; Cerebellar Diseases; Diagnosis, Differential; Humans; Levodopa; Muscle Rigidity | 1991 |
Hemiparkinsonism-hemiatrophy syndrome: clinical and neuroradiologic features.
Topics: Adolescent; Adult; Atrophy; Brain; Extremities; Female; Follow-Up Studies; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease, Secondary; Retrospective Studies; Syndrome; Tomography, X-Ray Computed | 1990 |
Dopamine agonists suppress visual-cortical reflex myoclonus.
Topics: Aged; Apomorphine; Atrophy; Carbidopa; Cerebellum; Drug Therapy, Combination; Electromyography; Epilepsies, Myoclonic; Ergolines; Evoked Potentials, Somatosensory; Evoked Potentials, Visual; Female; Humans; Levodopa; Lisuride; Olivary Nucleus; Photic Stimulation; Pons; Reflex; Visual Cortex | 1985 |